Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Sensory-cognitive and Physical Fitness Training in Mild Cognitive Impairment [NA]
A completed clinical trial evaluated sensory-cognitive and physical fitness training for people with mild cognitive impairment and mild Alzh…
-
CLINICAL_TRIALS research · 2016-07-13Clinical Trial Update: Effects of Visual Arts Training on Dementia [NA]
A York University trial investigates whether visual arts training affects dementia outcomes, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease [Phase 4]
Phase 4 trial evaluating safety and efficacy of donepezil HCl 23 mg in moderate to severe Alzheimer's disease; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: African American Alzheimer's Progression Markers - CSF and Neuro-Imaging
This update notes the completion of a clinical study evaluating cerebrospinal fluid biomarkers and neuro-imaging markers of Alzheimer's dise…
-
FDA approval · 2016-06-23FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a generic version of donepezil hydrochloride under an Original Application by Unichem Pharmaceuticals (USA), Inc. for the treat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-06-22FDA Approved: AMYVID — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for AMYVID (florbetapir F 18) filed by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Resveratrol for Alzheimer's Disease [Phase 2]
This document reports the completion of a Phase 2 trial evaluating resveratrol for Alzheimer's disease and notes that the trial results were…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of plasma exchange with 5% albumin for clearing beta-amyloid in cerebrospinal flui…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients [Phase 3]
Pfizer's Phase 3 trial of bapineuzumab for Alzheimer's disease was terminated and results were posted.
-
CLINICAL_TRIALS research · 2016-06-09Clinical Trial Update: Determinants of Quality of Life Related to Health in Alzheimer Disease
A clinical trial update describing research into determinants of health-related quality of life in individuals with Alzheimer disease.
-
FDA approval · 2016-06-07FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))
FDA approved a supplemental application for Vizamyl (flutemetamol F-18) submitted by GE Healthcare.
-
CLINICAL_TRIALS research · 2016-06-03Clinical Trial Update: Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment [NA]
This clinical trial entry evaluates whether a vegetal oil can impact cognitive impairment and Alzheimer's disease; phase and current status …
-
CLINICAL_TRIALS other · 2016-05-30Clinical Trial Update: A Study of Acupuncture for Patients With Behavioural and Psychological Symptoms of Dementia [Phase 1]
Phase 1 clinical trial evaluating acupuncture for behavioral and psychological symptoms in Alzheimer's disease and dementia; the study statu…
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Treatment of Behavioral Symptoms in Alzheimer's Disease [Phase 4]
A Phase 4 trial evaluating treatment of behavioral symptoms in Alzheimer's disease has completed, including psychosis and agitation.
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Oculomotor Testing in the Differential Diagnosis of Dementia [Phase 3]
Phase 3 clinical trial evaluating oculomotor testing to differentiate dementia with Lewy bodies from Alzheimer's disease; status completed.
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters [NA]
A completed study evaluating a telephone care consultation intervention for veterans with dementia and Alzheimer's disease; results were pos…
-
FDA approval · 2016-05-18FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for memantine hydrochloride from Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED) [Phase 2]
The Phase 2 clinical trial MK0952 in mild-to-moderate Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease [Phase 2]
A 36-week safety extension study of ELND005 for agitation and aggression in Alzheimer's disease was terminated; results posted in 2016.
-
CLINICAL_TRIALS research · 2016-05-13Clinical Trial Update: Neurostimulation and Cognitive Intervention in Alzheimer's Disease [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study evaluating neurostimulation and cognitive interventions for Alzheimer's disease…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease [Phase 1]
This Phase 1 trial assessed the short-term efficacy and safety of perispinal administration of etanercept in individuals with mild to modera…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men
This completed clinical trial examined cerebrospinal fluid biomarkers related to Alzheimer's disease in insulin-resistant men. Sponsored by …
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease [NA]
This report summarizes a completed clinical trial assessing how pharmacotherapy management affects outcomes in patients with Alzheimer's dis…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients
This clinical trial update reports on the tolerability of the Exelon Patch (rivastigmine) for patients with Alzheimer's disease and notes co…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025 [Phase 3]
This clinical trial update reports the termination of a Phase 3 study evaluating two doses of EVP-6124 in subjects with Alzheimer's disease …